Posted by linkadge on December 9, 2017, at 12:49:40
In reply to Re: Primavanserin (Nuplazid) - A new antipsychotic?, posted by Christ_empowered on December 9, 2017, at 12:36:52
A common feature of 'atypical' antispychotics is that they inhibited 5-ht2a/c and so (presumably) less dopamine antagonism was required for a theraputic effect.
I have not heard of a pure 5-ht2 antagonist working for schizophrenia. However, they could likely block visual hallicunations.
Linkadge
poster:linkadge
thread:1096249
URL: http://www.dr-bob.org/babble/20161215/msgs/1096288.html